Publication: Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis
No Thumbnail Available
Date
2020-10-01T00:00:00Z
Authors
Authors
Akarsu, Ozger
Baysal, Orhan
Karadag, Serhat
Gursu, Meltem
Ozkan, Oktay
Uzun, Sami
Gurdal, Ahmet
Cebeci, Egemen
Sumnu, Abdullah
Behlul, Ahmet
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Objective: There is a relationship between inflammation and cardiovascular disease (CVD) in patients with chronic kidney disease. Visfatin is an adipocytokine, which has been shown to be associated with inflammation, endothelial dysfunction, and CVD. Our study aimed to examine the relationship of visfatin with metabolic and echocardiographic parameters in patients on peritoneal dialysis (PD).
Description
Keywords
Citation
Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., Gurdal A., Cebeci E., Sumnu A., Behlul A., et al., -Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis-, TURKISH JOURNAL OF NEPHROLOGY, cilt.29, ss.297-303, 2020